BioRem Inc.
BRM.V · TSXV
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | CA$0 | CA$0 | CA$0 | CA$0 |
| % Growth | 48.7% | -12.8% | 17.9% | – |
| Cost of Goods Sold | CA$0 | CA$0 | CA$0 | CA$0 |
| Gross Profit | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 26.9% | 27.9% | 30.4% | 25.5% |
| R&D Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| G&A Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| SG&A Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| Sales & Mktg Exp. | CA$0 | CA$0 | CA$0 | CA$0 |
| Other Operating Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| Operating Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| Operating Income | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 11.6% | 12.2% | 9.1% | 8.5% |
| Other Income/Exp. Net | -CA$0 | -CA$0 | -CA$0 | -CA$0 |
| Pre-Tax Income | CA$0 | CA$0 | CA$0 | CA$0 |
| Tax Expense | CA$0 | CA$0 | CA$0 | CA$0 |
| Net Income | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 8.1% | 8.7% | 5.6% | 5.3% |
| EPS | 0.19 | 0.14 | 0.1 | 0.036 |
| % Growth | 35.7% | 40% | 177% | – |
| EPS Diluted | 0.16 | 0.13 | 0.092 | 0.035 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | CA$0 | CA$0 | CA$0 | CA$0 |
| Interest Expense | CA$0 | CA$0 | CA$0 | CA$0 |
| Depreciation & Amortization | CA$0 | CA$0 | CA$0 | CA$0 |
| EBITDA | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 12.9% | 13.7% | 10.4% | 10.9% |